Abide Therapeutics - Ownership and Business Overview

Life ScienceCompany

Abide Therapeutics Ownership

Who owns Abide Therapeutics?

Abide Therapeutics is owned by H. Lundbeck A/S. It was acquired on May 6, 2019.

Abide Therapeutics Business Overview

Where is Abide Therapeutics headquartered?

Abide Therapeutics is headquartered in San Diego, California.

What sector is Abide Therapeutics in?

Abide Therapeutics is a life science company.

When was Abide Therapeutics founded?

Abide Therapeutics was founded in 2011.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Abide Therapeutics, Inc.

10835 Road to the Cure, Suite 250,
San Diego, California 92121
United States,
(858) 427-2590
www.abidetx.com

Abide Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to realizing the therapeutic value of first-in-class endocannabinoid modulators to transform the lives of patients with serious unmet medical needs. Abide Therapeutics, Inc. was founded in 2011 and is based in San Diego, California.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.